Application of Nanomaterials in the Treatment and Diagnosis of Ophthalmology Diseases

Author(s): Nanxin Liu, Qingqing Wu, Yunfei Liu, Jiao Li, Ping Ji*, Gang Fu*

Journal Name: Current Stem Cell Research & Therapy

Volume 16 , Issue 1 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Eye diseases often lead to impaired vision and seriously affect the daily life of patients. Local administration of ophthalmic drugs is one of the most important approaches for the treatment of ophthalmic diseases. However, due to the special biochemical environment of the ocular tissue and the existence of many barriers, the bioavailability of conventional ophthalmic preparations in the eye is very low. Nanomaterials can be utilized as carriers of drugs, which can improve the absorption, distribution, metabolism and bioavailability of drugs in eyes. Nanomaterials have also the advantages of small size, simple preparation, good degradability, strong targeting, and little stimulation to biological tissues, providing an innovative and practical method for the drug delivery of ophthalmic diseases. In addition, nanomaterials can be used as an auxiliary means for early diagnosis of ophthalmic diseases by improving the specificity and accuracy of detection methods. Nanomaterials help clinicians and researchers delve deeper into the physiology and pathology of the eye at the nanoscale. We summarize the application of nanomaterials in the diagnosis and treatment of ophthalmic diseases in this review.

Keywords: Nanomaterials, drug-delivery, ophthalmology diseases, administration, bioavailability, auxiliary.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 1
Year: 2021
Published on: 01 December, 2021
Page: [95 - 103]
Pages: 9
DOI: 10.2174/1574888X15666200210104449
Price: $65

Article Metrics

PDF: 14